X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 63 filers reported holding X4 PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $465,719 | -58.1% | 427,265 | -25.4% | 0.20% | -26.4% |
| Q2 2023 | $1,111,201 | -62.6% | 572,784 | +2.0% | 0.26% | -51.6% |
| Q3 2021 | $2,970,000 | -20.5% | 561,421 | -2.3% | 0.55% | +22.6% |
| Q2 2021 | $3,736,000 | -24.5% | 574,712 | 0.0% | 0.45% | -41.3% |
| Q1 2021 | $4,948,000 | – | 574,712 | – | 0.76% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 1,717,589 | $3,006,000 | 1.17% |
| SV Health Investors, LLC | 311,490 | $545,000 | 0.66% |
| Bain Capital Life Sciences Investors, LLC | 3,019,540 | $5,284,000 | 0.51% |
| AIGH Capital Management LLC | 997,719 | $1,746,000 | 0.43% |
| Ikarian Capital, LLC | 1,372,022 | $2,402,000 | 0.32% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $586,000 | 0.29% |
| Worth Venture Partners, LLC | 250,144 | $438,000 | 0.20% |
| Sio Capital Management, LLC | 276,909 | $485,000 | 0.16% |
| BVF INC/IL | 847,879 | $1,484,000 | 0.06% |
| Orbimed Advisors | 1,373,849 | $2,404,000 | 0.04% |